Skip to main content Skip to footer

Ziegler Advises CancerIQ on Series B Private Placement Led by Merck and Amgen

Ziegler is pleased to announce it served as exclusive financial advisor to CancerIQ on a $14,000,000 Series B private placement led by Merck Global Health Innovation Fund and Amgen Ventures. McKesson Ventures, OSF Ventures, and existing investor, HealthX Ventures, also participated in the round.